Rating Change
Jefferies analysts downgraded Pediatrix Medical Group, Inc. (NYSE:MD) from Buy to Hold on August 19, 2026.
Jefferies analysts downgraded Pediatrix Medical Group, Inc. (NYSE:MD) from Buy to Hold on August 19, 2026.

At publication ·
Pediatrix Medical Group, Inc. (NYSE:MD) · downgrade
At a glance
Jefferies analysts downgraded Pediatrix Medical Group, Inc. (NYSE:MD) from Buy to Hold on August 19, 2026.
Pediatrix Medical Group, Inc. operates in the Healthcare sector. The stock currently trades at $26.22 with a market capitalization of $1.9B.
Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Jefferies's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 0 Buy, 10 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 19, 2026 | Jefferies | Hold | N/A |
| Aug 06, 2026 | UBS | Neutral | N/A |
| Jul 14, 2026 | Truist Securities | Hold | N/A |
| May 12, 2026 | UBS | Neutral | N/A |
| Apr 13, 2026 | Truist Securities | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View MD Stock Page
A rating of Hold from Jefferies reflects the analyst's outlook on Pediatrix Medical Group, Inc. (NYSE:MD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MD forecast page.
Current market data
NYSE · MD
$26.61
Down: -$0.34 · -1.28%
Live quote updated
Keep reading
price ·
sec_filing ·
earnings ·
sec_filing ·